Methyl 3-Oxovalerate - CAS 30414-53-0
Catalog: |
BB020586 |
Product Name: |
Methyl 3-Oxovalerate |
CAS: |
30414-53-0 |
Synonyms: |
3-oxopentanoic acid methyl ester; methyl 3-oxopentanoate |
IUPAC Name: | methyl 3-oxopentanoate |
Description: | Methyl 3-Oxovalerate (CAS# 30414-53-0) is used in the synthesis of anti-Perol stereospecific reductases that can be used in the asymmettric and environmentally friendly reduction of ketones. |
Molecular Weight: | 130.14 |
Molecular Formula: | C6H10O3 |
Canonical SMILES: | CCC(=O)CC(=O)OC |
InChI: | InChI=1S/C6H10O3/c1-3-5(7)4-6(8)9-2/h3-4H2,1-2H3 |
InChI Key: | XJMIXEAZMCTAGH-UHFFFAOYSA-N |
Boiling Point: | 95-97 °C (48 mmHg) |
Density: | 1.037 g/cm3 |
MDL: | MFCD00011705 |
LogP: | 0.52860 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-11046705-B1 | Method for preparing etodolac methyl ester | 20200318 |
US-2021171529-A1 | Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use | 20191125 |
WO-2021108404-A1 | Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use | 20191125 |
WO-2021075558-A1 | Adhesive, adhesive sheet and optical member | 20191018 |
WO-2021070132-A1 | Bi-aryl dihydroorotate dehydrogenase inhibitors | 20191010 |
PMID | Publication Date | Title | Journal |
22347087 | 20120201 | 2-Ethyl 4-methyl 5-ethyl-3-methyl-1H-pyrrole-2,4-dicarboxyl-ate | Acta crystallographica. Section E, Structure reports online |
22091116 | 20110801 | Dimethyl 3,5-diethyl-1H-pyrrole-2,4-dicarboxyl-ate | Acta crystallographica. Section E, Structure reports online |
17469647 | 20070101 | Studies on the synthesis and biological activitiy of 6-ethyl-4-aryl-5-methoxycarbonyl-3,4-dihydropyrimidin-2(1H)-ones | Arzneimittel-Forschung |
16971126 | 20061215 | Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1H)-thione derivatives as potential calcium channel blockers | Bioorganic & medicinal chemistry |
Complexity: | 118 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 130.062994177 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 130.062994177 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 43.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS